Skip to main content

Same RNA Acts in Neurodegeneration and Cancer

The long noncoding RNA MINCR, implicated in ALS and Alzheimer’s disease as well as several types of cancer, appears to function differently when present at high versus low levels.

Written byAbby Olena, PhD
| 3 min read
An artist's rendition of an RNA molecule in light blue on a dark blue background

Register for free to listen to this article
Listen with Speechify
0:00
3:00

ABOVE: © ISTOCK.COM,
LIBRE DE DROIT

Overexpression of a long noncoding RNA called MINCR causes many changes in expression levels of genes involved in cancer, according to a study published October 15 in Genomics, and its downregulation affects neurodegeneration-related genes. Finding a role for MINCR in both neurodegeneration and cancer hints at broad effects that lncRNAs are likely having in many pathological and developmental scenarios.

“There’s a lot of emerging data that connects brain cancer with normal developmental processes in the brain,” says John Prensner, a pediatric oncologist and researcher at Dana Farber Cancer Institute, Boston Children’s Hospital, and Harvard Medical School who was not involved in the study. “These [long noncoding] RNAs have multiple and flexible functions in different contexts,” he adds, “so one of the central strengths of the paper is to be able to start to tie together these different disease processes.”

Some estimates have put the number ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi
Advancing Research With Humanized Mouse Models

Advancing Research with Next-Generation Humanized Mouse Models

bioxcell
3d illustration showing amyloid plaques in Alzheimer's disease

Best Practices for Blood-Based Amyloid Pathology Testing

fujirebio logo
Optimizing Critical Steps in T-Cell Engineering

Optimizing Critical Steps in T-Cell Engineering

Fujifilm

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen